drugset / Trial / NCT01633099

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

NCT01633099

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to confirm the safety and the therapeutic effect of Decitabine in the treatment of elderly Acute Myeloid Leukemia (AML) patients.

Timeline

Start
2012-05
Primary completion
2014-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Decitabine Small molecule 20 mg/m2 Intravenous